THE UTILITY OF SOX ANTIBODIES FOR CANCER PREDICTION IN PATIENTS WITH PARANEOPLASTIC NEUROLOGICAL DISORDERS

THE UTILITY OF SOX ANTIBODIES FOR CANCER PREDICTION IN PATIENTS WITH PARANEOPLASTIC NEUROLOGICAL DISORDERS

Bibliographic Details
Main Authors:	Maddison, P, Titulaer, M, Verschuuren, J, Gozzard, P, Lang, B, Willcox, N, Vincent, A, Irani, SR, Chapman, C
Format:	Conference item
Published:	2012

Similar Items

The utility of anti-SOX2 antibodies for cancer prediction in patients with paraneoplastic neurological disorders
by: Maddison, P, et al.
Published: (2018)

Antibodies associated with paraneoplastic neurological disorders.
by: Vincent, A
Published: (2005)

Algorithm to improve the diagnosis of paraneoplastic neurological syndromes associated with SOX1 antibodies
by: Cristina Arnaldos-Pérez, et al.
Published: (2023-05-01)

Paraneoplastic neurological autoimmunity and survival in small-cell lung cancer.
by: Maddison, P, et al.
Published: (2008)

Paraneoplastic neurological syndromes: a practical approach to diagnosis and management
by: Binks, S, et al.
Published: (2021)

ANTI-HU PARANEOPLASTIC SENSORY NEURONOPATHY WITH UNDERLYING SQUAMOUS CELL CARCINOMA OF THE LUNG
by: Gozzard, P, et al.
Published: (2010)

Recommended diagnostic criteria for paraneoplastic neurological syndromes.
by: Graus, F, et al.
Published: (2004)

Anti-glial nuclear antibody: marker of lung cancer-related paraneoplastic neurological syndromes.
by: Graus, F, et al.
Published: (2005)

Review: Progress in the management of paraneoplastic neurological disorders
by: Hamid Sadeghian, et al.
Published: (2010-01-01)

Paraneoplastic neurological syndromes. State of the art
by: Giometto, B, et al.
Published: (2006)

Paraneoplastic neurological syndromes
by: Antoine Jean-Christophe, et al.
Published: (2007-05-01)

Caveats and Pitfalls of SOX1 Autoantibody Testing With a Commercial Line Blot Assay in Paraneoplastic Neurological Investigations
by: Raquel Ruiz-García, et al.
Published: (2019-04-01)

N-methyl-d-aspartate antibody encephalitis: Temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes
by: Irani, SR, et al.
Published: (2010)

N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes.
by: Irani, SR, et al.
Published: (2010)

Diagnosis of paraneoplastic neurological syndromes
by: Camilo E Fadul MD
Published: (2007-07-01)

Diagnosis of paraneoplastic neurological syndromes
by: Camilo E Fadul MD
Published: (2007-07-01)

PDE10A antibodies in autoimmune encephalitis: a possible marker of cancer immunotherapy?
by: Titulaer, MJ, et al.
Published: (2019)

Antiganglioside antibodies and paraneoplastic neuromuscular junction disorder?
by: Noushin Jazebi, et al.
Published: (2020-12-01)

EARLY AND CONTINUED TREATMENT OF N-METHYL D-ASPARTATE RECEPTOR-ANTIBODY ENCEPHALITIS OPTIMISES OUTCOME OF A PREDOMINANTLY NON-PARANEOPLASTIC DISEASE
by: Irani, SR, et al.
Published: (2009)

An overview on CV2/CRMP5 antibody-associated paraneoplastic neurological syndromes
by: Sai Wang, et al.
Published: (2023-01-01)

Anti-Ma2-antibody-associated encephalitis: An atypical paraneoplastic neurologic syndrome
by: Bogna Targonska, et al.
Published: (2018-05-01)

Novel Humoral Prognostic Markers in Small-Cell Lung Carcinoma: A Prospective Study.
by: Paul Gozzard, et al.
Published: (2015-01-01)

Diagnosis and Treatment of Paraneoplastic Neurologic Syndromes
by: Daniel Chiu, et al.
Published: (2023-07-01)

Neurological manifestation of cancer – paraneoplastic syndromes
by: Szklener Katarzyna, et al.
Published: (2021-06-01)

Role of ion channel autoantibodies in NK-cell antibody-dependent anti-tumour immunity in patients with paraneoplastic Lambert-Eaton syndrome
by: Tschernatsch, M, et al.
Published: (2009)

Simultaneous paraneoplastic cerebellar degeneration, Lambert-Eaton syndrome and neuropathy associated with AGNA/anti-SOX1 and VGCC antibodies
by: Jonas Feldheim, et al.
Published: (2021-05-01)

Anti-Ma2 Antibody-Associated Paraneoplastic Neurological Syndromes: A Pilot Study
by: Yi Guo, et al.
Published: (2021-11-01)

Antibody‐positive autoimmune encephalitis and paraneoplastic neurological syndrome: A Swedish case series
by: Sonja Kosek, et al.
Published: (2024-05-01)

N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes
by: Irani, S, et al.
Published: (2010)

Autoimmune and paraneoplastic seizures
by: Wagner, B, et al.
Published: (2024)

Paraneoplastic neurologic syndrome: A practical approach
by: Sudheeran Kannoth
Published: (2012-01-01)

Ovarian Teratoma-Related Paraneoplastic Neurological Syndromes
by: Jingfang Lin, et al.
Published: (2022-05-01)

Paraneoplastic neurological syndromes: clinical presentations and management
by: Michelle F. Devine, et al.
Published: (2021-01-01)

Predicting disability and mortality in CV2/CRMP5‐IgG associated paraneoplastic neurologic disorders
by: Sanem P. Uysal, et al.
Published: (2024-03-01)

A case of paraneoplastic neurological syndrome expressing dual antineuronal antibodies: Anti-hu and recoverin
by: Ho-Sung Ryu, et al.
Published: (2020-01-01)

P/Q type calcium-channel antibodies in paraneoplastic cerebellar degeneration with lung cancer.
by: Graus, F, et al.
Published: (2002)

Contactin-associated protein-2 antibodies in non-paraneoplastic cerebellar ataxia.
by: Becker, E, et al.
Published: (2012)

Contactin-associated protein-2 antibodies in non-paraneoplastic cerebellar ataxia.
by: Becker, E, et al.
Published: (2012)

Thymoma and paraneoplastic myasthenia gravis.
by: Marx, A, et al.
Published: (2010)

Clinical characteristics and immunotherapy response in paraneoplastic neurologic syndrome patients with increased number of high-risk antibodies
by: Gong Wang, et al.
Published: (2025-01-01)